Compare Mutual Funds
Quant Healthcare Fund
Select a Mutual Fund
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹1000
-
Expense Ratio
3.13
-
NAV
₹18.37
-
Fund Started
27 Jun 2023
-
Fund Size
₹428.30 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
1 Year
16.22%
-
3 Year
18.94%
-
5 Year
-
-
Equity
98.98%
-
Cash
-4.55%
-
Top 10 Holdings
Glaxosmithkline Pharmaceuticals Ltd. | 10.58% |
Glenmark Pharmaceuticals Ltd. | 9.83% |
Divi's Laboratories Ltd. Warrant | 9.46% |
Zydus Lifesciences Ltd. | 9.30% |
Pfizer Ltd. | 8.83% |
Alivus Life Sciences Ltd | 8.08% |
Torrent Pharmaceuticals Ltd. | 7.87% |
Concord Biotech Ltd. | 7.03% |
SMS Pharmaceuticals Ltd. | 6.71% |
Ipca Laboratories Ltd. | 6.22% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
-
Launch Date
27 Jun 2023
-
